The recently retired director of the UNC Diabetes Center is presenting on GLP-1 drugs next Tuesday. The event listing has the details.
Recap by typeshit. Post by Facebook on Facebook.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
A regular weekday of meals and food tracking from a creator on a GLP-1, built around what she had in the kitchen. A thin, familiar format.
BioPharma APAC counts 12 generic makers since Novo's patent lapsed in March. Some vials run about Rs 1,300 a month, and generics hit half of sales by April.
Loading…